Preview Mode Links will not work in preview mode

The Retina Channel Podcast

The Retina Channel is an ophthalmology journal club discussing new scientific articles focused on retina. The target audience are eye care professionals who are interested in the most recent advances in retina.

“Our mission is to facilitate transmission of knowledge from researchers to their target audience.”

  1. All Episodes
  2. E64-DRCR Protocol AC-Aflibercept Monotherapy or Bevacizumab First for DME- Dr. Chirag Jhaveri

E64-DRCR Protocol AC-Aflibercept Monotherapy or Bevacizumab First for DME- Dr. Chirag Jhaveri

Oct 30, 2022

Dr. Jhavery discusses results of DRCR Retina Protocol AC study which compared DME response to anti-VEGF injections in patients who received Aflibercept monotherapy vs those who started with Bevacizumab first and then switched to Aflibercept if needed. 

Discussed article:

Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. PMID: 35833805.